BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6261804)

  • 21. Differential control of the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary. Response to serotonin.
    Randle JC; Moor BC; Kraicer J
    Neuroendocrinology; 1983 Aug; 37(2):131-40. PubMed ID: 6310431
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence that glycosylation of pro-opiocortin and ACTH influences their proteolysis by trypsin and blood proteases.
    Loh YP; Gainer H
    Mol Cell Endocrinol; 1980 Oct; 20(1):35-44. PubMed ID: 6254821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthesis of polyprotein precursors to regulatory peptides.
    Herbert E; Uhler M
    Cell; 1982 Aug; 30(1):1-2. PubMed ID: 6290073
    [No Abstract]   [Full Text] [Related]  

  • 24. Biosynthesis and distribution of opioid peptides.
    Imura H; Nakai Y; Nakao K; Oki S; Tanaka I; Jingami H; Yoshimasa T; Tsukada T; Ikeda Y; Suda M; Sakamoto M
    J Endocrinol Invest; 1983 Apr; 6(2):139-49. PubMed ID: 6134767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for intragranular processing of pro-opiocortin in the mouse pituitary intermediate lobe.
    Loh YP; Gritsch HA
    Eur J Cell Biol; 1981 Dec; 26(1):177-83. PubMed ID: 6276180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of pro-adrenocorticotropin/endorphin-derived peptides.
    Eipper BA; Mains RE
    J Biol Chem; 1982 May; 257(9):4907-15. PubMed ID: 7068671
    [No Abstract]   [Full Text] [Related]  

  • 28. Corticotropin releasing factor stimulates adrenocorticotropin and beta-endorphin release from AtT-20 mouse pituitary tumor cells.
    Hook VY; Heisler S; Sabol SL; Axelrod J
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1364-71. PubMed ID: 6288045
    [No Abstract]   [Full Text] [Related]  

  • 29. Steps involved in the processing of common precursor forms of adrenocorticotropin and endorphin in cultures of mouse pituitary cells.
    Roberts JL; Phillips M; Rosa PA; Herbert E
    Biochemistry; 1978 Aug; 17(17):3609-18. PubMed ID: 210798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression of peptides: the pro-opiomelanocortin model.
    Seidah NG; Larivière N; Boileau G; Gossard F; Hsi KL; Lu CL; Chrétien M
    Adv Biochem Psychopharmacol; 1982; 33():19-26. PubMed ID: 6289623
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of glycosilation of pro-opiomelanocortin might account for the periodic acid-Schiff-negative reaction in ACTH cells of teleost fishes.
    Iturriza FC; Estivariz FE
    Gen Comp Endocrinol; 1986 Feb; 61(2):229-36. PubMed ID: 3007268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant changes of ACTH, beta-endorphin and N-terminal portion of pro-opiomelanocortin in rats.
    Lis M; Larivière N; Maurice G; Julesz J; Seidah N; chrétien M
    Life Sci; 1982 Apr; 30(14):1159-64. PubMed ID: 6283283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of pro-opiocortin-related peptides in post-mortem mouse brain tissue.
    Ratter SJ; Ackland J; Corder R; Emson P; Rossor M; Tomlin S; Rees LH
    Neuroendocrinology; 1982 Nov; 35(5):336-41. PubMed ID: 6292765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and maturation process of pro-opiomelanocortin: a model for other neuropeptides.
    Chrétien M; Gossard F; Crine P; Gianoulakis C; Seidah NG
    Adv Biochem Psychopharmacol; 1980; 22():153-66. PubMed ID: 7395596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ACTH, beta-endorphin, lipotropins, and other pro-opiocortin-derived peptides: a new family of hormones (author's transl)].
    Bertagna X; Luton JP; Bricaire H
    Ann Med Interne (Paris); 1982; 133(3):145-7. PubMed ID: 6285790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcellular fractionation studies on the post-translational processing of pro-adrenocorticotropic hormone/endorphin in rat intermediate pituitary.
    Glembotski CC
    J Biol Chem; 1981 Jul; 256(14):7433-9. PubMed ID: 6265449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic mediation of the effect of elevated potassium on the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary.
    Randle JC; Moor BC; Kraicer J
    Neuroendocrinology; 1983 Aug; 37(2):141-9. PubMed ID: 6193453
    [No Abstract]   [Full Text] [Related]  

  • 38. Processing of normal and non-glycosylated forms of toad pro-opiocortin by rat intermediate (pituitary) lobe pro-opiocortin converting enzyme activity.
    Loh YP; Gainer H
    Life Sci; 1982 Dec; 31(26):3043-50. PubMed ID: 6298538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of contacts between proopiomelanocortin neurons in the rat hypothalamus.
    Chen YY; Pelletier G
    Neurosci Lett; 1983 Dec; 43(2-3):271-6. PubMed ID: 6324045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of asparagine-linked glycosylation of pro-opiomelanocortin in mouse pituitary cells by DL-threo-beta-fluoroasparagine.
    Phillips MA; Stern AM; Abeles RH; Tashjian AH
    J Pharmacol Exp Ther; 1983 Jul; 226(1):276-81. PubMed ID: 6864547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.